Nested Randomized Controlled Trials in Large Databases: An Opportunity for Inflammatory Bowel Disease? - Takeaways - MDSpire

Nested Randomized Controlled Trials in Large Databases: An Opportunity for Inflammatory Bowel Disease?

  • By

  • Maria Jose Temido

  • Sailish Honap

  • Silvio Danese

  • Vipul Jairath

  • Fernando Magro

  • Francisco Portela

  • Laurent Peyrin-Biroulet

  • August 29, 2024

  • 0 min

Share

  • 1

    Nested randomized controlled trials (RCTsNC) are designed to address challenges in traditional RCTs by utilizing existing patient cohorts.

  • 2

    RCTsNC enhance patient recruitment and follow-up processes, making them more economical compared to conventional randomized trials.

  • 3

    This trial design allows for the use of longitudinal data to assess safety and efficacy over longer periods.

  • 4

    Despite their advantages, RCTsNC face limitations such as selection bias and challenges in placebo comparisons.

  • 5

    RCTsNC have not yet been applied in inflammatory bowel disease research, presenting a unique opportunity for future studies.

Original Source(s)

Related Content